Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder
This study has been completed.
Study NCT00216294   Information provided by Indiana University
First Received: September 13, 2005   Last Updated: July 14, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obsessive Compulsive Disorder (OCD)
Additional conditions recognized in this trial
Disease
Obsessive-Compulsive Disorder
More general conditions related to this trial
Anxiety Disorders
Mental Disorders
Pathologic Processes
Interventions listed in this trial
RG1068 (Synthetic Human Secretin)
Additional drug interventions recognized in this trial
Secretin
More general drug interventions related to this trial
Gastrointestinal Agents
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Indiana University School of Medicine
Shekhar, Anantha M.D., Ph.D.
Repligen Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services